Sterling Capital Management’s Precision BioSciences DTIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.96K Sell
473
-11
-2% -$83 ﹤0.01% 3066
2026
Q2
$3.8K Buy
+484
New +$3.41K ﹤0.01% 2760

Other funds holding DTIL

Sterling Capital Management's DTIL Position: Q3 2026 in Review

Sterling Capital Management reduced its Precision BioSciences (DTIL) stake by 2.3% in Q3 2026, selling an estimated $83 and leaving 473 shares worth $2.96K. The position accounts for ﹤0.01% of the portfolio, ranked #3066.

Sterling Capital Management first reported a position in DTIL in Q2 2026 and has held it in 2 quarters since. The position peaked at $3.8K in Q2 2026. 109 funds tracked by Wall St. Rank hold DTIL as of Q3 2026.

  • Sterling Capital Management held 473 shares of Precision BioSciences worth $2.96K as of Q3 2026.
  • Sterling Capital Management sold 11 Precision BioSciences shares in Q3 2026, an estimated $83.
  • Precision BioSciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #3066 holding.
  • Sterling Capital Management first reported a position in Precision BioSciences in Q2 2026 and has held it in 2 quarters since.
  • Sterling Capital Management's Precision BioSciences position peaked at $3.8K in Q2 2026.
  • 109 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.